Clinical Trials Logo

Filter by:
NCT ID: NCT05126602 Completed - COVID-19 Clinical Trials

Vitamin D Supplementation and Clinical Improvement in COVID-19

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Background and objective Vitamin D is important as the interaction between vitamin D and its receptors at the immune cells stimulates innate and adaptive immunity. Deficiency in vitamin D is associated with increased susceptibility to infection and it is commonly found in Indonesia. Several studies indicate the potential of vitamin D supplementation against Coronavirus Disease 2019 (COVID-19), particularly in combating the proinflammatory situation as well as coagulopathy. This study aims to evaluate the supplementation of vitamin D in COVID 19 patients, particularly the changes in hematology parameters and other clinical parameters. Method A double-blind randomized clinical trial is conducted among moderate COVID 19 patients. High-dose of vitamin D is given orally in the intervention group, compared with a low dose of vitamin D. Hematology parameters, D Dimer, conversion time on Polymerase Chain Reaction (PCR) test, and clinical symptoms are assessed Hypothesis High Dose vitamin D shows a better hematology parameter, short PCR conversion time, and faster clinical recovery

NCT ID: NCT05124340 Completed - Clinical trials for BCG Vaccination Reaction

Safety and Tuberculin Conversion Following BCG Vaccination

Start date: December 1, 2021
Phase: Phase 2
Study type: Interventional

The study is an bridging study, observer-blind, randomized, controlled prospective intervention study. The primary objective is evaluate the safety of BCG Vaccine Vial (Bio Farma).

NCT ID: NCT05122234 Completed - COVID-19 Clinical Trials

Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19

Start date: August 10, 2020
Phase: Phase 3
Study type: Interventional

This study is a multi-centre randomized controlled trial involving severe covid-19 patients. The intervention group will receive mesenchymal stem cell secretomes and standard covid-19 therapy, while the control group receive placebo and standard covid-19 therapy. Clinical presentation, inflamatory marker, laboratory and radiological parameters, RT-PCR conversion, safety profile, and mortality rate will be monitored for a maximum of 14 days after intervention.

NCT ID: NCT05119218 Completed - Stunting Clinical Trials

Gut Microbiota Stunted Children NTT

Start date: November 2, 2021
Phase:
Study type: Observational [Patient Registry]

NTT Province is on the list of priority areas of high prevalence of stunting, Southwest Sumba, South Middle East, and Kupang district have a stunting prevalence of 36.2%, 34.5% and 48.1% respectively in 2020. Therefore, it is necessary to conduct a profile study. microbiota, SCFA, gastrointestinal integrity, parasites, hygiene practice, and cognition in stunting and healthy toddlers in the province of East Nusa Tenggara,

NCT ID: NCT05118542 Completed - Graves Disease Clinical Trials

Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis

Start date: January 1, 2019
Phase: Phase 3
Study type: Interventional

During July 2019 to August 2020, a single-blind clinical trial was done to 36 patients with Graves' disease. At the beginning of the study, subjects were accommodated into 2 groups, 17 into PTU groups and 19 into methimazole groups. There were 24 subjects who finished the study, 13 from PTU group and 11 from methimazole group. Blood serum was collected for HOMA-IR, LDL-R, NFĸB, sICAM-1, sVCAM-1 and sE-selectin examination. Meanwhile stiffness and thickness of carotid artery was measured using PWV and cIMT.

NCT ID: NCT05113823 Completed - Clinical trials for COVID-19 Respiratory Infection

In Situ Simulation Training in Transferring Critically Ill COVID-19 Patients

Start date: November 16, 2020
Phase: N/A
Study type: Interventional

This study aimed to determine the role of in situ simulation training during a pandemic by using standard and high-fidelity mannequins to improve interprofessional communication, skills, and teamwork in transferring critically ill COVID-19 patients.

NCT ID: NCT05112978 Completed - Clinical trials for Patello Femoral Syndrome

Evaluation of Patellar Dimension and Bristol Index in Asian Population

Start date: January 1, 2019
Phase:
Study type: Observational

Restoration of patellar thickness is pivotal during a total knee arthroplasty (TKA). Several studies showed there are differences in the knee measurements between Asian and Western population. This study aims to evaluate the patellar dimension and Bristol Index of patellar width to thickness (BIPWiT) using magnetic resonance imaging (MRI) in Asian population.

NCT ID: NCT05110469 Completed - Shivering Clinical Trials

Comparison of MgSO4 Versus Meperidine for Prevention of Shivering During Spinal Anesthesia

Start date: February 1, 2021
Phase: Phase 4
Study type: Interventional

This was a double-blind randomized interventional study of 100 patients divided into two groups. Group M received MgSO4 30 mg/kg, and group P received meperidine 0.5 mg/kg intravenously in 100 ml of 0.9% NaCl before undergoing spinal anesthesia. Participants were non-pregnant patients between 18-65 years of age, belonging to the American Society of Anesthesiologist physical status I or II. Shivering was regarded as significant if it occurred at grade 3 or 4. Data of patient characteristics, shivering degree, tympanic membrane temperature, vital sign, and side effects were recorded.

NCT ID: NCT05104489 Completed - COVID-19 Clinical Trials

Dose-finding Study for AdimrSC-2f Vaccine

Start date: January 3, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

AdimrSC-2f is a subunit protein-based vaccine produced using the baculovirus insect cells manufacturing process to prevent Coronavirus disease 2019 (COVID-19). The primary goal of this Phase I/II study is to evaluate the vaccine safety and immunogenicity of AdimrSC-2f in healthy adult individuals, as compared to placebo.

NCT ID: NCT05104203 Completed - Analgesia Clinical Trials

TLIP Block Versus Modified TLIP Block for Posterior Decompression and Stabilization Surgery

Start date: January 21, 2021
Phase: N/A
Study type: Interventional

This study aimed to compare the analgesia effectivity of TLIP and modified TLIP block in Posterior Lumbar Decompression and Stabilization Surgery Perioperatively.